J. Dirk Iglehart

15.2k citations

138 papers · 10.8k indexed · 2 hit papers · h-index 57

Molecular Biology top 1%
Oncology top 0.2%
Cancer Research top 0.2%
Genetics top 0.5%
Pathology and Forensic Medicine top 0.5%

Co-authors: Jeffrey R. Marks Zhigang C. Wang Andrew M. Davidoff Alexander Miron Xin Lü Debajit K. Biswas Andrea L. Richardson Peter A. Humphrey
Topics: Breast Cancer Treatment Studies (23 papers)HER2/EGFR in Cancer Research (21 papers)BRCA gene mutations in cancer (18 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Cell Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States Denmark China

In The Last Decade

J. Dirk Iglehart

138 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

X chromosomal abnormalities in basal-like human breast cancer

2006 668 citations Andrea L. Richardson, Zhigang C. Wang et al. profile →
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer

2015 347 citations Yubao Wang, Tinghu Zhang et al. Cell profile →

Peers

Countries citing papers authored by J. Dirk Iglehart

Since Specialization

Citations

This map shows the geographic impact of J. Dirk Iglehart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Dirk Iglehart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Dirk Iglehart more than expected).

Fields of papers citing papers by J. Dirk Iglehart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Dirk Iglehart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Dirk Iglehart. The network helps show where J. Dirk Iglehart may publish in the future.

Co-authorship network of co-authors of J. Dirk Iglehart

This figure shows the co-authorship network connecting the top 25 collaborators of J. Dirk Iglehart. A scholar is included among the top collaborators of J. Dirk Iglehart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Dirk Iglehart. J. Dirk Iglehart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020) 2015 ·Annals of Surgical Oncology ·Faina Nakhlis,Lauren Gilmore,Rebecca Gelman,Isabelle Bedrosian,Kandice K. Ludwig,Eunjoo Hwang,Shawna C. Willey,Clifford A. Hudis,J. Dirk Iglehart,Elizabeth Lawler,Nicole Ryabin,Mehra Golshan,Stuart J. Schnitt,Tari A. King	59
2	RelA-Induced Interferon Response Negatively Regulates Proliferation 2015 ·PLoS ONE ·Bose Kochupurakkal,Zhigang C. Wang,(unknown),Aedín C. Culhane,Scott J. Rodig,(unknown),(unknown),Andrea L. Richardson,Debajit K. Biswas,J. Dirk Iglehart	18
3	CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancerbreakdown → 2015 ·Cell ·Yubao Wang,Tinghu Zhang,Nicholas Kwiatkowski,Brian J. Abraham,Tong Ihn Lee,Shaozhen Xie,Haluk Yuzugullu,Thanh Von,Heyuan Li,Ziao Lin,Daniel G. Stover,Elgene Lim,Zhigang C. Wang,J. Dirk Iglehart,Richard A. Young,Nathanael S. Gray,Jean J. Zhao	347
4	NF-κB Activation-Induced Anti-apoptosis Renders HER2-Positive Cells Drug Resistant and Accelerates Tumor Growth 2013 ·Molecular Cancer Research ·Shannon T. Bailey,Penelope Miron,Yoon Jong Choi,Bose Kochupurakkal,Gautam Maulik,Scott J. Rodig,Ruiyang Tian,Kathleen M. Foley,Teresa V. Bowman,Alexander Miron,Myles Brown,J. Dirk Iglehart,Debajit K. Biswas	42
5	Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents 2012 ·Cancer Discovery ·Nicolai J. Birkbak,Zhigang C. Wang,Ji-Young Kim,Aron C. Eklund,Qiyuan Li,Ruiyang Tian,Christian Bowman-Colin,Yang Li,April Greene-Colozzi,J. Dirk Iglehart,Nadine Tung,Paula D. Ryan,Judy E. Garber,Daniel P. Silver,Zoltán Szállási,Andrea L. Richardson	412
6	BEAMing Up Personalized Medicine: Mutation Detection in Blood 2012 ·Clinical Cancer Research ·Andrea L. Richardson,J. Dirk Iglehart	38
7	The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis 2012 ·Genes & Development ·Tamara Utermark,(unknown),Hailing Cheng,Qi Wang,Sang‐Hyun Lee,Zhigang C. Wang,J. Dirk Iglehart,Thomas M. Roberts,William J. Muller,Jean J. Zhao	112
8	The amplified cancer gene LAPTM4B promotes tumor growth and tolerance to stress through the induction of autophagy 2012 ·Autophagy ·Yang Li,J. Dirk Iglehart,Andrea L. Richardson,Zhigang Charles Wang	25
9	Lysosomal Transmembrane Protein LAPTM4B Promotes Autophagy and Tolerance to Metabolic Stress in Cancer Cells 2011 ·Cancer Research ·(unknown),Qing Zhang,Ruiyang Tian,Qi Wang,Jean J. Zhao,J. Dirk Iglehart,Zhigang Charles Wang,Andrea L. Richardson	73
10	PIK3CA Mutations in In situ and Invasive Breast Carcinomas 2010 ·Cancer Research ·Alexander Miron,Mária Váradi,Daniel R. Carrasco,Hailun Li,Lauren Luongo,Hee Jung Kim,So Yeon Park,Eun Yoon Cho,(unknown),Sarah M. Kehoe,J. Dirk Iglehart,Deborah Dillon,D. Craig Allred,Laura E. MacConaill,Rebecca Gelman,Kornélia Polyák	107
11	Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival 2008 ·Breast Cancer Research and Treatment ·Andrea C. Bafford,Harold J. Burstein,Christina R. Barkley,Barbara L. Smith,Stuart R. Lipsitz,J. Dirk Iglehart,Eric P. Winer,Mehra Golshan	125
12	Nuclear factor-κB activation: a molecular therapeutic target for estrogen receptor–negative and epidermal growth factor receptor family receptor–positive human breast cancer 2007 ·Molecular Cancer Therapeutics ·(unknown),Qian Shi,Shannon T. Bailey,(unknown),Arthur B. Pardee,J. Dirk Iglehart,Debajit K. Biswas	71
13	Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer 2007 ·Clinical Cancer Research ·Lyndsay N. Harris,Fanglei You,Stuart J. Schnitt,Agnes Witkiewicz,Xin Lü,Dennis C. Sgroi,Paula D. Ryan,Steven E. Come,Harold J. Burstein,(unknown),(unknown),Paula N. Friedman,Rebecca Gelman,J. Dirk Iglehart,Eric P. Winer	190
14	Amplification of chromosome 8q22 and metastasis of breast cancers 2006 ·Cancer Research ·Zhigang C. Wang,Yan Li,J. Dirk Iglehart,Andrea L. Richardson	2
15	Genome-Wide Analysis for Loss of Heterozygosity in Primary and Recurrent Phyllodes Tumor and Fibroadenoma of Breast using Single Nucleotide Polymorphism Arrays 2006 ·Breast Cancer Research and Treatment ·Zhigang Charles Wang,(unknown),J. Dirk Iglehart,Andrea Richardson	29
16	Pre-Counseling Education Materials for BRCA Testing: Does Tailoring Make a Difference? 2002 ·Genetic Testing ·Celette Sugg Skinner,Joellen M. Schildkraut,Donald A. Berry,Brian Calingaert,P. Kelly Marcom,Jeremy Sugarman,Eric P. Winer,J. Dirk Iglehart,P. Andrew Futreal,Barbara K. Rimer	58
17	Rate-limiting effects of Cyclin D1 in transformation by ErbB2 predicts synergy between herceptin and flavopiridol. 2002 ·PubMed ·Rita Nahta,J. Dirk Iglehart,Bettina Kempkes,Emmett V. Schmidt	42
18	Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy. 2001 ·PubMed ·Lyndsay N. Harris,Lu Yang,Vlayka Liotcheva,Stefan Pauli,J. Dirk Iglehart,O. Michael Colvin,T S Hsieh	64
19	A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. 1995 ·PubMed ·David H. Harpole,(unknown),Walter G. Wolfe,J. Dirk Iglehart,(unknown)	252
20	Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. 1989 ·PubMed ·H Lacroix,J. Dirk Iglehart,Mhairi Skinner,M H Kraus	144

About J. Dirk Iglehart

J. Dirk Iglehart is a scholar working on Cancer Research, Oncology and Genetics, having authored 138 papers that have together received 10.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), HER2/EGFR in Cancer Research (21 papers) and BRCA gene mutations in cancer (18 papers). The work is most often cited by research in Cancer Research (3.2k citations), Oncology (4.8k citations) and Molecular Biology (5.5k citations). J. Dirk Iglehart has collaborated with scholars based in United States, Denmark and China. Frequent co-authors include Jeffrey R. Marks, Zhigang C. Wang, Andrew M. Davidoff, Alexander Miron, Xin Lü, Debajit K. Biswas, Andrea L. Richardson, Peter A. Humphrey, Andrea L. Richardson and Andrew Berchuck. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact